Aquatic Capital Management’s Twist Bioscience TWST Stock Holding History

Aquatic Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66M	Buy	+35,574	New	+$2.31M	0.13%	209
2026 Q1	–	Sell	-78,469	Closed	-$2.49M	–	1821
2025 Q4	$2.49M	Buy	78,469 +56,206	+252%	+$1.75M	0.07%	329
2025 Q3	$626K	Sell	22,263 -40,056	-64%	-$1.21M	0.01%	811
2025 Q2	$2.29M	Buy	+62,319	New	+$2.15M	0.05%	438
2025 Q1	–	Sell	-61,100	Closed	-$2.84M	–	1645
2024 Q4	$2.84M	Buy	61,100 +7,100	+13%	+$321K	0.08%	310
2024 Q3	$2.44M	Buy	54,000 +52,700	+4,054%	+$2.51M	0.06%	319
2024 Q2	$64.1K	Sell	1,300 -49,900	-97%	-$2.03M	﹤0.01%	976
2024 Q1	$1.76M	Buy	+51,200	New	+$1.85M	0.06%	272
2023 Q2	–	Sell	-32,600	Closed	-$492K	–	1753
2023 Q1	$492K	Buy	+32,600	New	+$720K	0.03%	417
2022 Q4	–	Sell	-2,700	Closed	-$95K	–	1840
2022 Q3	$95K	Buy	+2,700	New	+$115K	0.01%	765
2022 Q2	–	Sell	-1,000	Closed	-$49K	–	1579
2022 Q1	$49K	Buy	+1,000	New	+$55.4K	0.07%	287

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Aquatic Capital Management's TWST Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 35,574 shares worth $3.66M. The stake represents 0.13% of the portfolio and ranks #209 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in TWST as recently as Q4 2025.

Aquatic Capital Management first reported a position in TWST in Q1 2022 and has held it in 11 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Aquatic Capital Management held 35,574 shares of Twist Bioscience worth $3.66M as of Q2 2026.
Twist Bioscience was a new Aquatic Capital Management position in Q2 2026.
Twist Bioscience made up 0.13% of Aquatic Capital Management's portfolio in Q2 2026, its #209 holding.
Aquatic Capital Management first reported a position in Twist Bioscience in Q1 2022 and has held it in 11 quarters since.
336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.